Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arch Therapeutics Inc (OTCBB - OTCQB:ARTH)

During the Trading Day
0.365 -0.0045 / -1.22%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.363 -0.002 / -0.55%
 
Volume: --
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$28.9M

Company Description

Arch Therapeutics, Inc. is a medical device company, which offers an innovative, elegant, and superior approach to the rapid cessation of bleeding and control of fluid leakage during surgery and trauma care. Its product candidate surgical hemostatic device is designed to achieve hemostasis in minimally invasive and open surgical procedures. Arch Therapeutics was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Wellesley, MA.

Contact Information

Arch Therapeutics, Inc.
235 WALNUT STREET
Framingham Massachusetts 01702
P:(617) 431-2313
Investor Relations:

Employees

Shareholders

Individual stakeholders23.87%
Mutual fund holders--
Other institutional--

Top Executives

Terrence W. NorchiPresident, Chief Executive Officer & Director
William M. CotterChief Operating Officer & Head-Manufacturing
Richard E. DavisChief Financial Officer & Treasurer
Chirag ShahVice President-Research & Development Engineering
Steven A. KatesVice President-Technology